In vitro activity of LY 264826 compared with that of vancomycin against 100 clinical isolates each of methicillin-resistant Staphylococcus aureus and Clostridium difficile

Autor: Fasola, E L, Moody, J A, Gerding, D N, Peterson, L R
Zdroj: Antimicrobial Agents and Chemotherapy; October 1990, Vol. 34 Issue: 10 p2007-2008, 2p
Abstrakt: The in vitro activity of LY 264826, a new glycopeptide antibiotic, was compared with that of vancomycin against 100 strains each of methicillin-resistant Staphylococcus aureus and Clostridium difficile. LY 264826 was more active, by weight, than vancomycin against the isolates tested. The human serum protein binding of LY 264826 was 15.3% (range, 9.8 to 21.8%).
Databáze: Supplemental Index